Form 8-K - Current report:
SEC Accession No. 0000950170-22-001856
Filing Date
2022-02-24
Accepted
2022-02-24 07:02:31
Documents
18
Period of Report
2022-02-24
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K clnn-20220224.htm   iXBRL 8-K 69809
2 EX-99.1 clnn-ex99_1.htm EX-99.1 33396
3 EX-99.2 clnn-ex99_2.htm EX-99.2 2058
4 EX-99.3 clnn-ex99_3.htm EX-99.3 1293
5 GRAPHIC clnn-ex99_2s1.jpg GRAPHIC 104215
6 GRAPHIC clnn-ex99_3s1.jpg GRAPHIC 110786
  Complete submission text file 0000950170-22-001856.txt   640746

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clnn-20220224.xsd EX-101.SCH 3354
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clnn-20220224_lab.xml EX-101.LAB 36339
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT clnn-20220224_def.xml EX-101.DEF 28536
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clnn-20220224_pre.xml EX-101.PRE 29690
12 EXTRACTED XBRL INSTANCE DOCUMENT clnn-20220224_htm.xml XML 6635
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39834 | Film No.: 22666469
SIC: 2834 Pharmaceutical Preparations